In this episode of the businessline podcast, Aishwarya Narendra Kumar speaks with Suraj Jain, Clinical Operations Head at Manipal Truist, to address the growing concerns about human metapneumovirus (hMPV). With cases of hMPV emerging across various Indian states, the discussion clears up misconceptions about the virus. 

Jain explains that hMPV, while resembling the flu in its symptoms, is not a new threat—it’s been present in India since 2003 and is part of a family of respiratory viruses that have existed for decades. 

The podcast explores how hMPV spreads through respiratory droplets and what precautions can be taken to prevent infection, especially in households with young children or the elderly. 

He goes on to highlight that most cases are mild, with common symptoms like nasal congestion, cough, and sore throat. Recovery typically happens within 10 to 15 days, with mortality being extremely rare, particularly among immunocompromised individuals or those in higher-risk age groups. 

Additionally, Jain emphasises the lower contagiousness of hMPV when compared to more recent viruses like COVID-19, explaining that it’s not likely to lead to a pandemic. The discussion also touches on the lack of a vaccine for hMPV, as its low severity and widespread exposure make it less of a public health concern compared to more deadly viruses. Listen in!